84 related articles for article (PubMed ID: 1036744)
1. The in vitro suppression of lectin induced 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil.
Wall JR; Manwar GL; Greenwood DM; Walters BA
J Clin Endocrinol Metab; 1976 Dec; 43(6):1406-9. PubMed ID: 1036744
[TBL] [Abstract][Full Text] [Related]
2. Effects of antithyroid drugs on lymphocyte proliferative responses to lectins: relationship between insulin autoimmune syndrome and methimazole.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Aug; 11(4):167-71. PubMed ID: 6689431
[TBL] [Abstract][Full Text] [Related]
3. Anti-thyroid drugs and lymphocyte function. I. The in vitro effect on blastogenesis and suppressor cell activity.
Goldrath N; Eisenstein Z; Bank H; Shoham J
Clin Exp Immunol; 1982 Oct; 50(1):55-61. PubMed ID: 6217000
[TBL] [Abstract][Full Text] [Related]
4. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
5. Effects of antithyroid drugs on lymphocyte function in vitro.
Hallengren B; Forsgren A; Melander A
J Clin Endocrinol Metab; 1980 Aug; 51(2):298-301. PubMed ID: 7400298
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
7. Anti-thyroid drugs and lymphocyte function. II. The in vivo effect on blastogenesis and suppressor cell activity in Graves' disease.
Goldrath N; Shoham J; Bank H; Eisenstein Z
Clin Exp Immunol; 1982 Oct; 50(1):62-9. PubMed ID: 6217001
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism.
Okamura K; Ikenoue H; Shiroozu A; Sato K; Yoshinari M; Fujishima M
J Clin Endocrinol Metab; 1987 Oct; 65(4):719-23. PubMed ID: 3654917
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
[TBL] [Abstract][Full Text] [Related]
11. Graves' disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil.
Sato K; Miyakawa M; Han DC; Kato S; Shibagaki Y; Tsushima T; Shizume K
J Endocrinol Invest; 1985 Dec; 8(6):551-5. PubMed ID: 3841726
[TBL] [Abstract][Full Text] [Related]
12. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence.
Fischman CM; Udey MC; Kurtz M; Wedner HJ
J Immunol; 1981 Dec; 127(6):2257-62. PubMed ID: 6975313
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
15. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
Wenzel KW; Lente JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
Chattaway JM; Klepser TB
Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
Shiroozu A; Taurog A; Engler H; Dorris ML
Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
[TBL] [Abstract][Full Text] [Related]
18. The effect of antithyroid drugs on B and T cell activity in vitro.
Wilson R; McKillop JH; Chopra M; Thomson JA
Clin Endocrinol (Oxf); 1988 Apr; 28(4):389-97. PubMed ID: 2461267
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil (PTU) pharmacology in the rat. II. Effects of PTU on thyroid function.
Cooper DS; Kieffer JD; Halpern R; Saxe V; Mover H; Maloof F; Ridgway EC
Endocrinology; 1983 Sep; 113(3):921-8. PubMed ID: 6872961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
